January 13, 2025--(BUSINESS WIRE)--Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today provided recent corporate updates and highlighted upcoming ...

Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease ...

Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. PT (4:30 p.m. ET) - Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading muscle disease ...

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Edgewise Therapeutics (EWTX – Research Report) today. The company’s shares closed yesterday at $25.33. Discover ...

We can readily understand why investors are attracted to unprofitable companies. For example, Edgewise Therapeutics (NASDAQ:EWTX) shareholders have done very well over the last year, with the share ...

Elizaldy Co. One of the solutions being offered to fix the present budget debacle is to return the “very, very bad budget” – in the words of presidential sister Senator Imee Marcos – to ...

“A Big Idea to Solve America’s Immigration Mess” (editorial, Jan. 12) was a thoughtful and comprehensive discussion of most of the difficult issues that arise when trying to deal with our ...

Investors in Edgewise Therapeutics Inc (Symbol: EWTX) saw new options become available today, for the December 19th expiration. One of the key inputs that goes into the price an option buyer is ...

SCOTTSDALE, Ariz. − Penn State football coach James Franklin was asked how to fix college football two days before his team plays, perhaps, its biggest game in years. What can be done ...

Sevilla player Enrique Salas has been detained by police for allegedly earning yellow cards intentionally in order to fix sports betting results, LaLiga said Tuesday. According to Spanish news ...

A new patch was released yesterday that was supposed to fix a lot of the issues, but since its release, players have reported that there are still a lot of technical problems. Players reported ...

Edgewise Therapeutics (NASDAQ:EWTX) is building itself up as a good long-term biotech to hang onto. Especially, when you consider that it was able to report positive results from its phase 2 ...